-
American Journal of Industrial Medicine Nov 2017Styrene is a chemical used in the manufacture of plastic-based products worldwide. We systematically reviewed eligible studies of occupational styrene-induced... (Meta-Analysis)
Meta-Analysis Review
BACKGROUND
Styrene is a chemical used in the manufacture of plastic-based products worldwide. We systematically reviewed eligible studies of occupational styrene-induced dyschromatopsia, qualitatively synthesizing their findings and estimating the exposure effect through meta-analysis.
METHODS
PubMed, EMBASE, and Web of Science databases were queried for eligible studies. Using a random effects model, we compared measures of dyschromatopsia between exposed and non-exposed workers to calculate the standardized mean difference (Hedges'g). We also assessed between-study heterogeneity and publication bias.
RESULTS
Styrene-exposed subjects demonstrated poorer color vision than did the non-exposed (Hedges' g = 0.56; 95%CI: 0.37, 0.76; P < 0.0001). A non-significant Cochran's Q test result (Q = 23.2; P = 0.171) and an I of 32.2% (0.0%, 69.9%) indicated low-to-moderate between-study heterogeneity. Funnel plot and trim-and-fill analyses suggested publication bias.
CONCLUSIONS
This review confirms the hypothesis of occupational styrene-induced dyschromatopsia, suggesting a modest effect size with mild heterogeneity between studies.
Topics: Color Vision Defects; Humans; Occupational Diseases; Occupational Exposure; Styrene
PubMed: 28836685
DOI: 10.1002/ajim.22766 -
Indian Journal of Ophthalmology Mar 2023The extended use of ethambutol beyond 2 months for treating tuberculosis has increased risk of optic neuropathy. We performed a systematic review of studies evaluating... (Review)
Review
The extended use of ethambutol beyond 2 months for treating tuberculosis has increased risk of optic neuropathy. We performed a systematic review of studies evaluating optic neuropathy in extended ethambutol use since 2010 and compared the outcome with a similar systematic review (1965-2010) by Ezer et al. Literature search was conducted in PubMed, Medline, EMBASE, and Cochrane databases. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Main outcome measures were visual acuity, color vision, visual field defects, optical coherence tomography (OCT), and visual evoked potential (VEP). The JBI Critical Appraisal Checklists were used for quality assessment. Twelve studies were selected (out of 639 studies) for analysis of ethambutol optic neuropathy. Visual acuity improvement after stopping ethambutol was statistically significant. Similar improvement was not noted for other outcome measures. On comparing the results of this review with those by Ezer et al., significant improvement was noted in visual acuity, color vision, and visual field defects. Moreover, more patients reported increased optic nerve toxicity, color vision defects, and visual field defects in the present review. Hence, we conclude that the extended use of ethambutol beyond 2 months results in significant optic nerve toxicity. Further randomized controlled trials with different populations are needed to understand the magnitude of this issue.
Topics: Humans; Ethambutol; Evoked Potentials, Visual; Optic Nerve Diseases; Optic Nerve; Checklist; Rare Diseases
PubMed: 36872667
DOI: 10.4103/ijo.IJO_1920_22 -
Archivos de La Sociedad Espanola de... Jan 2017To evaluate recent evidence concerning the relationship between the exposure to organic solvents and the impairment of colour vision. (Review)
Review
OBJECTIVE
To evaluate recent evidence concerning the relationship between the exposure to organic solvents and the impairment of colour vision.
METHODS
A bibliographic search was conducted for scientific papers published in the last 15 years, in the LILACS, PubMed, Science Direct, EBSCO, and Cochrane databases that included observational studies assessing the relationship between impairment in colour vision and exposure to organic solvents.
RESULTS
Eleven studies were selected that were performed on an economically active population and used the Lanthony D-15 desaturated test (D-15d), measured the exposure to organic solvents, and included unexposed controls. It was found that there is a statistically significant relationship between the exposure to organic solvents and the presence of an impairment in colour vision.
CONCLUSIONS
The results support the hypothesis that exposure to organic solvents could induce acquired dyschromatopsia. The evaluation of colour vision with the D-15d test is simple and sensitive for diagnosis. More studies need to be conducted on this subject in order to better understand the relationship between impaired colour vision and more severe side effects caused by this exposure.
Topics: Air Pollutants, Occupational; Color Perception Tests; Color Vision Defects; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Occupational Diseases; Occupational Exposure; Organic Chemicals; Solvents
PubMed: 27422480
DOI: 10.1016/j.oftal.2016.05.008 -
Genetics in Medicine : Official Journal... Mar 2022This study aimed to systematically review and summarize gene therapy treatment for monogenic retinal and optic nerve diseases. (Review)
Review
PURPOSE
This study aimed to systematically review and summarize gene therapy treatment for monogenic retinal and optic nerve diseases.
METHODS
This review was prospectively registered (CRD42021229812). A comprehensive literature search was performed in Ovid MEDLINE, Ovid Embase, Cochrane Central, and clinical trial registries (February 2021). Clinical studies describing DNA-based gene therapy treatments for monogenic posterior ocular diseases were eligible for inclusion. Risk of bias evaluation was performed. Data synthesis was undertaken applying Synthesis Without Meta-analysis guidelines.
RESULTS
This study identified 47 full-text publications, 50 conference abstracts, and 54 clinical trial registry entries describing DNA-based ocular gene therapy treatments for 16 different genetic variants. Study summaries and visual representations of safety and efficacy outcomes are presented for 20 unique full-text publications in RPE65-mediated retinal dystrophies, choroideremia, Leber hereditary optic neuropathy, rod-cone dystrophy, achromatopsia, and X-linked retinoschisis. The most common adverse events were related to lid/ocular surface/cornea abnormalities in subretinal gene therapy trials and anterior uveitis in intravitreal gene therapy trials.
CONCLUSION
There is a high degree of variability in ocular monogenic gene therapy trials with respect to study design, statistical methodology, and reporting of safety and efficacy outcomes. This review improves the accessibility and transparency in interpreting gene therapy trials to date.
Topics: Color Vision Defects; Genetic Therapy; Humans; Optic Nerve Diseases; Retina; Retinal Dystrophies
PubMed: 34906485
DOI: 10.1016/j.gim.2021.10.013 -
Occupational Medicine (Oxford, England) Jun 2016Occupational colour vision testing is a requirement in a number of transport industries, and there are a number of tests that are considered acceptable by the various... (Review)
Review
BACKGROUND
Occupational colour vision testing is a requirement in a number of transport industries, and there are a number of tests that are considered acceptable by the various industry regulatory bodies.
AIMS
To review the occupational colour vision tests currently in use nationally and internationally and determine whether they give consistent results.
METHODS
A systematic review of the evidence was carried out according to standard methods. The Ovid Medline database was searched from 1946 to March 2013 using a broad and inclusive strategy.
RESULTS
A total of 8951 citations were identified, from which 20 papers were selected for data analysis. Of these papers, 13 of 20 assessed test sensitivity and specificity, and 11 papers measured the number, type and severity of colour vision deficiency of subjects passing the tests. Three studies also measured test repeatability. The quality of studies included was generally good. Sensitivity and specificity ranged from 64% to 100% and 88% to 100%, respectively. The studies evaluating the newer screen-based tests reported the highest sensitivity and specificity. The marked variability reported between tests and within tests can be attributed to many factors including test protocol, sample selection, test distance and time for dark adaptation.
CONCLUSIONS
There was low consistency between the colour vision tests examined. Lantern tests cannot be used to identify type or severity of colour vision deficit and, when used as a screening test for 'colour safe' status, give variable results. These results highlight the need for standardization across the transport industries.
Topics: Color Vision; Color Vision Defects; Humans; Occupational Health Services; Sensitivity and Specificity
PubMed: 27162253
DOI: 10.1093/occmed/kqw012